EUVIMEDEUVIMED entdecken
Open Access

Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations

Cleison Ledesma Taira iD, Lucas Dos Santos Dias, Sarah Lichtenberger, Alexander J Whitehead iD, Brenda Kischkel iD, Mihai G Netea, Bruce S Klein, Marcel Wüthrich

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2400065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Cleison Ledesma Taira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI. Hauptthemen laut MEDLINE: Fungal Vaccines, Immunity, Innate, Candidiasis, Mannans. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, ERC advanced grant, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida spp. are the fourth leading cause of bloodstream infections in hospitalized patients and the most common cause of invasive fungal infection. No vaccine against Candida spp. or other fungal pathogens of humans is available. We recently discovered the Blastomyces Dectin-2 ligand endoglucanase 2 that harbors antigenic and adjuvant functions and can function as a protective vaccine against that fungus. We also reported that the adjuvant activity, which is mediated by O-mannans decorating the C terminus of Blastomyces Dectin-2 ligand endoglucanase 2, can augment peptide Ag-induced vaccine immunity against heterologous agents, including Cryptococcus, Candida, and influenza. In this article, we report that the O-linked mannans alone, in the absence of any antigenic peptide, can also protect against systemic candidiasis, reducing kidney fungal load and increasing survival in a Dectin-2–dependent manner. We found that this long-term glycan-induced protection is mediated by innate lymphocyte populations including TCR-γδ+ T cells, innate lymphoid cells, and NK cells that subsequently activate and release reactive oxygen species from neutrophils and monocytes. Our findings suggest that Blastomyces O-mannan displayed by Eng2 induces a form of protective trained immunity mediated by innate lymphocyte populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fungal VaccinesImmunity, InnateCandidiasisMannansMiceAnimalsBlastomycesLectins, C-TypeMice, Inbred C57BLVaccinationKiller Cells, NaturalHumansMice, Knockout

Substanzen

Fungal VaccinesMannansLectins, C-Typedectin-2, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
  • Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Internal Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
  • Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.

ORCID-Profile: Cleison Ledesma Taira, Alexander J Whitehead, Brenda Kischkel

Förderung

  • NIAID NIH HHS
  • ERC advanced grant
  • HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID)
  • NCI NIH HHS
  • Spinoza Grant of the Netherlands Organization for Scientific Research
  • American Heart Association (AHA)
  • NIH HHS
  • Foundation for the National Institutes of Health (FNIH)

Zitieren

APA

Taira, C. L., Dos Santos Dias, L., Lichtenberger, S., Whitehead, A. J., Kischkel, B., Netea, M. G., Klein, B. S., & Wüthrich, M. (2024). Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400065

Vancouver

Taira CL, Dos Santos Dias L, Lichtenberger S, Whitehead AJ, Kischkel B, Netea MG, et al. Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400065

BibTeX
@article{Taira2024,
  author = {Taira, Cleison Ledesma and Dos Santos Dias, Lucas and Lichtenberger, Sarah and Whitehead, Alexander J and Kischkel, Brenda and Netea, Mihai G and Klein, Bruce S and Wüthrich, Marcel},
  title = {Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2400065}
}
Kostenlos starten →